Flynn James E 13D and 13G filings for Werewolf Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:11 pm Sale | 2021-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL | Flynn James E | 958,125 3.470% | -1,594,662 (-62.47%) | Filing |
| 2021-05-04 12:33 pm Purchase | 2021-05-04 | 13G | Werewolf Therapeutics, Inc. HOWL | Flynn James E | 2,552,787 9.270% | 2,552,787 (New Position) | Filing |